You’re not new to the captive world. You’ve had your captive for several years and generally feel good about its performance. However, you’re now in one of the most difficult markets we’ve seen in a while.
In this GCP Short, produced in partnership with MAXIS Global Benefits Network, we explore findings from the network's latest whitepaper on GLP-1s, often known as weight-loss drugs.
Richard is joined by Mat Robinson, Senior Managing Director and Captive Operations Leader, and Matt Gravelin, Managing Director in Consulting at Brown & Brown, to discuss how organisations can hone their captive strategy and achieve strong internal buy-in from across the group.
